Today is Friday, November 21, 2008.
NEWS SEARCH:    [home | site terms] Juvantia Pharma discovers and develops pharmaceuticals for neurological and cardiovascular disorders with the ultimate goal to offer new treatment possibilities and increase safety margins to patients and reduce the costs to society.   Juvantia News 05.09.2006 Santhera and Juvantia to Collaborate on Development of Phase II Product for Dyskinesia in Parkinson’s Disease 05.09.2006 Santhera ja Juvantia Yhteistyöhön - Tavoitteena kehittää tuote Parkinsonin taudin liikehäiriöiden hoitoon Updated 05.09.2006 Juvantia Lemminkäisenkatu 5, PharmaCity, 20520 Turku, Finland. Tel: +358 2 6517 1500. Fax: +358 2 6517 1599
verkkovaraani, 2003